- Home
- GSL vs BVS Comparison
GSL vs BVS Comparison
Compare GSL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSL
- BVS
- Stock Information
- Founded
- GSL 2007
- BVS 2011
- Country
- GSL Greece
- BVS United States
- Employees
- GSL N/A
- BVS N/A
- Industry
- GSL Marine Transportation
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GSL Consumer Discretionary
- BVS Health Care
- Exchange
- GSL Nasdaq
- BVS Nasdaq
- Market Cap
- GSL 753.1M
- BVS 883.7M
- IPO Year
- GSL 2006
- BVS 2021
- Fundamental
- Price
- GSL $21.23
- BVS $10.67
- Analyst Decision
- GSL Strong Buy
- BVS Strong Buy
- Analyst Count
- GSL 1
- BVS 3
- Target Price
- GSL $29.00
- BVS $15.00
- AVG Volume (30 Days)
- GSL 401.9K
- BVS 315.8K
- Earning Date
- GSL 11-11-2024
- BVS 11-05-2024
- Dividend Yield
- GSL 7.76%
- BVS N/A
- EPS Growth
- GSL 7.30
- BVS N/A
- EPS
- GSL 8.96
- BVS N/A
- Revenue
- GSL $701,476,000.00
- BVS $555,061,000.00
- Revenue This Year
- GSL $6.45
- BVS $11.24
- Revenue Next Year
- GSL N/A
- BVS $6.77
- P/E Ratio
- GSL $2.37
- BVS N/A
- Revenue Growth
- GSL 8.60
- BVS 10.40
- 52 Week Low
- GSL $18.75
- BVS $3.90
- 52 Week High
- GSL $30.32
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- GSL 34.07
- BVS 39.69
- Support Level
- GSL $21.10
- BVS $10.95
- Resistance Level
- GSL $21.89
- BVS $11.59
- Average True Range (ATR)
- GSL 0.60
- BVS 0.57
- MACD
- GSL 0.00
- BVS -0.08
- Stochastic Oscillator
- GSL 16.18
- BVS 19.90
About GSL Global Ship Lease Inc New
Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of the company's revenues are derived from charters to MAERSK. Its fleet consisted of more than 60 containerships.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.